## ADPT: Adaptive Biotechnologies Corpor - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_10 at 7.6% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($14.92)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. First Week of February 2026 Options Trading For Adaptive Biotechnologies (ADPT)**
- Source: Nasdaq | 20251219T160924 | Neutral | Relevance: 100%
- New options for Adaptive Biotechnologies (ADPT) for February 2026 expiration have started trading, with BNK Invest highlighting particular put and call contracts. A put contract at the $15.00 strike price offers a potential 0.67% return if it expires worthless, while a covered call strategy at the $17.50 strike price could yield a 6.84% return. The article details potential returns and risks for investors considering these option strategies.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.16M) |
| Sells | 14 ($10.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Viking Global Invest: 19.7% (0.0%)
- Blackrock Inc.: 8.8% (-2.3%)
- Vanguard Group Inc: 7.4% (-0.0%)
- Ameriprise Financial: 3.9% (+84.3%)
- Sumitomo Mitsui Trus: 2.4% (-15.1%)

### Key Risks

1. High beta (2.20) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $11M sold (14 transactions in 90 days).
3. Elevated short interest (8.7%): bears positioning against stock.

### Catalysts

- Momentum building: MRS_10 improving +8.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.57 indicates undervaluation relative to growth. Balance sheet: strong liquidity (3.4x). Insider selling cluster ($10.8M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.6B |
| Beta | 2.20 |
| 52W Range | $5.84 - $20.76 |
| Short Interest | 8.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.57 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 strengthening from -0.3% to 7.6% (+8.0% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (7.6% > 6.0%), caution on chasing. MRS_5 at 3.4% confirms short-term momentum alignment. Outperforming sector by 7.7pp, stock-specific strength. Long-term uptrend intact (above SMA200 at 1.42x) but short-term weakness (below SMA20). RSI neutral at 54. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.63% (CS: 98) | Strong |
| RSI_14 | 54.5 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 1.031x | Above |
| vs SMA200 | 1.416x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $17.00
- **Stop Loss:** $14.92 (12.2% risk)
- **Target:** $19.08 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 576
- **Position Value:** $9,792.00
- **Portfolio %:** 9.79%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-10 (Est: $-0.18)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.14 | $0.06 | +143.3% |
| 2025Q2 | $-0.24 | $-0.17 | +28.6% |
| 2025Q1 | $-0.31 | $-0.20 | +35.5% |
| 2024Q4 | $-0.24 | $-0.23 | +5.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*